These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11824891)

  • 21. Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus.
    Sutton IJ; Fursdon Davis CJ; Esiri MM; Hughes S; Amyes ER; Vincent A
    Ann Neurol; 2001 Feb; 49(2):253-7. PubMed ID: 11220746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium buffering capacity.
    Panja D; Vedeler CA; Schubert M
    Neuropathol Appl Neurobiol; 2019 Feb; 45(2):141-156. PubMed ID: 29679372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
    Tanaka K; Tanaka M; Onodera O; Igarashi S; Tsuji S
    No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA antigens in paraneoplastic cerebellar degeneration associated with anti-Yo antibody.
    Tanaka M; Tanaka K; Tsuji S
    Neurodegeneration; 1994 Dec; 3(4):341-2. PubMed ID: 7842305
    [No Abstract]   [Full Text] [Related]  

  • 25. Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies.
    Vialatte de Pémille C; Berzero G; Small M; Psimaras D; Giry M; Daniau M; Sanson M; Delattre JY; Honnorat J; Desestret V; Alentorn A
    Br J Cancer; 2018 Jul; 119(1):105-113. PubMed ID: 29899393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
    Tanaka M; Tanaka K; Onodera O; Tsuji S
    Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
    Yshii L; Bost C; Liblau R
    Front Immunol; 2020; 11():991. PubMed ID: 32655545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraneoplastic cerebellar degeneration. Case report and literature review.
    Bolla L; Palmer RM
    Arch Intern Med; 1997 Jun; 157(11):1258-62. PubMed ID: 9183238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction.
    Debes JD; Lagarde SM; Hulsenboom E; Sillevis Smitt PA; ten Kate FJ; Sulter GA; van Lanschot JJ
    Dig Surg; 2007; 24(5):395-7. PubMed ID: 17785986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Shinozawa K; Idezuka J; Tsuji S
    J Neurol Sci; 1998 Nov; 161(1):88-90. PubMed ID: 9879687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.
    Raspotnig M; Haugen M; Thorsteinsdottir M; Stefansson I; Salvesen HB; Storstein A; Vedeler CA
    Cancer Immunol Immunother; 2017 Nov; 66(11):1463-1471. PubMed ID: 28710511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review.
    Le May M; Dent S
    Curr Oncol; 2018 Dec; 25(6):e585-e591. PubMed ID: 30607127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term course of change in anti-Yo antibody content in paraneoplastic cerebellar degeneration.
    Tanaka K; Tanaka M; Igarashi S; Onodera O; Nakajima T; Yamazaki M; Miyatake T; Tsuji S
    J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):256-7. PubMed ID: 7876871
    [No Abstract]   [Full Text] [Related]  

  • 35. CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration.
    Kråkenes T; Herdlevaer I; Raspotnig M; Haugen M; Schubert M; Vedeler CA
    Ann Neurol; 2019 Aug; 86(2):316-321. PubMed ID: 31148214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature review.
    Ogita S; Llaguna OH; Feldman SM; Blum R
    Breast J; 2008; 14(4):382-4. PubMed ID: 18540952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
    Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
    PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies.
    Bradwell AR
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):19-29. PubMed ID: 11064823
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system.
    Giometto B; Marchiori GC; Nicolao P; Scaravilli T; Lion A; Bardin PG; Tavolato B
    Neuropathol Appl Neurobiol; 1997 Dec; 23(6):468-74. PubMed ID: 9460712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.